133 related articles for article (PubMed ID: 15026555)
1. Retinoic acid-induced CD38 antigen as a target for immunotoxin-mediated killing of leukemia cells.
Mehta K; Ocanas L; Malavasi F; Marks JW; Rosenblum MG
Mol Cancer Ther; 2004 Mar; 3(3):345-52. PubMed ID: 15026555
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
4. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.
Mehta K; McQueen T; Manshouri T; Andreeff M; Collins S; Albitar M
Blood; 1997 May; 89(10):3607-14. PubMed ID: 9160665
[TBL] [Abstract][Full Text] [Related]
5. Induction of CD38/NADase and its monoclonal antibody-induced tyrosine phosphorylation in human leukemia cell lines.
Kontani K; Kukimonto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Katada T
Biochem Biophys Res Commun; 1996 May; 222(2):466-71. PubMed ID: 8670228
[TBL] [Abstract][Full Text] [Related]
6. Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid.
Drach J; Zhao S; Malavasi F; Mehta K
Biochem Biophys Res Commun; 1993 Sep; 195(2):545-50. PubMed ID: 7690555
[TBL] [Abstract][Full Text] [Related]
7. Concentrative influx of functionally active cyclic ADP-ribose in dimethyl sulfoxide-differentiated HL-60 cells.
Guida L; Franco L; Bruzzone S; Sturla L; Zocchi E; Basile G; Usai C; De Flora A
J Biol Chem; 2004 May; 279(21):22066-75. PubMed ID: 15028729
[TBL] [Abstract][Full Text] [Related]
8. Nuclear CD38 in retinoic acid-induced HL-60 cells.
Yalcintepe L; Albeniz I; Adin-Cinar S; Tiryaki D; Bermek E; Graeff RM; Lee HC
Exp Cell Res; 2005 Feb; 303(1):14-21. PubMed ID: 15572023
[TBL] [Abstract][Full Text] [Related]
9. Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD19- and anti-CD38-saporin immunotoxins used in combination than with either immunotoxin used alone.
Flavell DJ; Boehm DA; Emery L; Noss A; Ramsay A; Flavell SU
Int J Cancer; 1995 Jul; 62(3):337-44. PubMed ID: 7543082
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line.
Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU
Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895
[TBL] [Abstract][Full Text] [Related]
11. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD38 in human promyelocytic leukemia HL-60 cell line during differentiation by niacin-related compounds.
Iwata K; Ogata S; Okumura K; Taguchi H
Biosci Biotechnol Biochem; 2003 Aug; 67(8):1836-9. PubMed ID: 12951526
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinases are involved in the all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells.
Lewandowski D; Linassier C; Iochmann S; Degenne M; Domenech J; Colombat P; Binet C; Hérault O
Br J Haematol; 2002 Aug; 118(2):535-44. PubMed ID: 12139742
[TBL] [Abstract][Full Text] [Related]
14. ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation.
de Toledo FG; Cheng J; Liang M; Chini EN; Dousa TP
Circ Res; 2000 Jun; 86(11):1153-9. PubMed ID: 10850967
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron.
Kishimoto H; Hoshino S; Ohori M; Kontani K; Nishina H; Suzawa M; Kato S; Katada T
J Biol Chem; 1998 Jun; 273(25):15429-34. PubMed ID: 9624127
[TBL] [Abstract][Full Text] [Related]
16. Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice.
Xu Y; Xu Q; Rosenblum MG; Scheinberg DA
Leukemia; 1996 Feb; 10(2):321-6. PubMed ID: 8637241
[TBL] [Abstract][Full Text] [Related]
17. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout.
MacDonald RJ; Shrimp JH; Jiang H; Zhang L; Lin H; Yen A
Sci Rep; 2017 Dec; 7(1):17406. PubMed ID: 29234114
[TBL] [Abstract][Full Text] [Related]
18. Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties.
Umar S; Malavasi F; Mehta K
J Biol Chem; 1996 Jul; 271(27):15922-7. PubMed ID: 8663150
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma.
Goldmacher VS; Bourret LA; Levine BA; Rasmussen RA; Pourshadi M; Lambert JM; Anderson KC
Blood; 1994 Nov; 84(9):3017-25. PubMed ID: 7524764
[TBL] [Abstract][Full Text] [Related]
20. NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38.
Kontani K; Nishina H; Ohoka Y; Takahashi K; Katada T
J Biol Chem; 1993 Aug; 268(23):16895-8. PubMed ID: 8394323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
